Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period

Human Immunology

Volumn 59, Issue 5, 1998, Pages 275-286

  Itescu, S ^a   Kwiatkowski, P ^a   Artrip, J H ^a   Wang, S F ^a   Ankersmit, J ^a   Minanov, O P ^a   Michler, R E ^a  

^a Division of Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2; LYMPHOKINE; MONOCLONAL ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BABOON; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRIMATE; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, HETEROPHILE; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; MACROPHAGES; MICROSCOPY, FLUORESCENCE; PAPIO; SWINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031965879     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00026-3     Document Type: Article

References (45)

1. Sandrin MS, Vaughan HA, Dabkowski PL, Mckenzie IFC. Anti-pig IgM antibodies in human serum react predominantly with Gal (alpha 1-3)Gal epitopes. Proc Natl Acad Sci USA. 90:1993;11391.
2. Cooper DKC, Good AH, Koren E, Oriol R, Malcolm AJ, Ippolito RM, Neethling FA, Ye Y, Romano E, Zuhdi N. Identification of alpha-galactosyl residues and other carbohydrate epitopes that are bound by human anti-pig antibodies relevance to discordant xenografting in man . Transpl Immunol. 1:(3):1993;198.
3. Rosengard AM, Cary N, Horsley J, Belcher C, Langford G, Cozzi E, Wallwork J, White DJ. Endothelial expression of human decay accelerating factor in transgenic pig tissue a potential approach for human complement inactivation in discordant xenografts . Transplant Proc. 27:(1):1995;326.
4. Sandrin MS, Fodor WL, Mouhtouris E, Osman M, Cohney S, Rollins SA, Guilmette ER, Setter E, Squinto SP, McKenzie IFC. Enzymatic remodeling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Medicine. 12:1995;1261.
5. Sharma A, Okabe J, Birch P, McClellan SB, Martin MJ, Platt JL, Logan JS. Reduction in the level of Gal (alpha 1,3) Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc Natl Acad Sci USA. 93:1996;7190.
6. Hancock WW, Blakely ML, Van der Werf W, Bach FH. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation. Transplant Proc. 25:1993;2932.
7. Inverardi L, Samaja M, Motterlini R, Mangili F, Bender JR, Pardi R. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol. 149:1992;1416.
8. Malyguine AM, Saadi S, Platt JL, Dawson JR. Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers. Transplantation. 61:1996;161.
9. Watier H, Guillaumin JM, Piller F, Lacord M, Thibault G, Lebranchu Y, Monsigny M, Bardos P. Removal of terminal alpha-galactosyl residues from xenogeneic porcine endothelial cells Decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity . Transplantation. 62:1996;105.
10. Itescu S, Kwiatkowski P, Wang SF, Minanov O, Rose S, Michler RE. Circulating human mononuclear cells exhibit augmented lysis of pig endothelium following activation with IL-2. Transplantation. 62:1996;1927.
11. Xu H, Edwards NM, Chen JM, Kwiatkowski P, Rosenberg SE, Michler RE. Newborn baboon serum lacks natural anti-pig xenoantibody. Transplantation. 59:(8):1995;1189.
12. Kaplon RJ, Michler RE, Xu H, Kwiatkowski PA, Edwards N, Platt J. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation. 59:1995;1.
13. Michler RE, Xu H, O'Hair DP, Kwiatkowski P, Minanov OM, Itescu S. Newborn discordant cardiac xenotransplantation in primates a model of natural antibody depletion . Transplant Proc. 28:1996;661.
14. Minanov O, Itescu S, Neethling F, Morgenthau A, Kwiatkowski P, Cooper DKC, Michler RE. Anti-gal IgG antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation. Transplantation. 63:1997;182.
15. Blakely ML, Van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation. 58:(10):1994;1059.
16. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration the multistep paradigm . Cell. 76:(2):1994;301.
17. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 11:1993;767.
18. Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte to cultured endothelial cell. J Cell Biol. 107:(1):1986;321.
19. Pober JS, Lapierre LA, Stolpen AH, Brock TA, Springer TA, Fiers W, Bevilacqua MP, Mendrick DL, Gimbrone MA Jr. Activation of cultured human endothelial cells by recombinant lymphotoxin comparison with tumor necrosis factor and interleukin 1 species . J Immunol. 138:(10):1987;3319.
20. Osborn L, Hession C, Tizard R, Vassalo C, Luhowskyj S, Chi-Rosso, Lobb R. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 59:(6):1989;1203.
21. Swerlick RA, Garcia-Gonzalez E, Kubota Y, Xu YL, Lawley TJ. Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells. J Invest Dermatol. 97:(2):1991;190.
22. Galea P, Lebranchu Y, Thibault G, Bardos P. Interleukin 4 and tumour necrosis factor alpha induce different adhesion pathways in endothelial cells for the binding of peripheral blood lymphocytes. Scand J Immunol. 36:(4):1992;575.
23. Kaji M, Ishikura H, Kishimoto T, Omi M, Ishizu A, Kimura C, Takahashi T, Kato H, Yoshiki T. E-selectin expression induced by pancreas-carcinoma-derived interleukin 1 alpha results in enhanced adhesion of pancreas-carcinoma cells to endothelial cells. Int J Cancer. 60:(5):1995;712.
24. Inverardi L, Pardi R. Early events in cell-mediated recognition of vascularized xenografts cooperative interactions between selected lymphocyte subsets and natural antibodies . Immunol Rev. 141:1994;71.
25. Itescu S, Artrip J, Kwiatkowski P, Wang SF, Morgenthau A, Minanov O, Michler RE. Lysis of pig endothelium by IL-2 activated human NK cell is inhibited by human and swine MHC class I gene products. Ann Transplant. 2:(1):1997;14.
26. Damle NK, Doyle LV, Bender JR, Bradley EC. Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J Immunol. 138:(6):1987;1779.
27. Kotasek D, Vercellotti GM, Ochoa AC, Bach FH, White JG, Jacob HS. Mechanism of cultured endothelial injury induced by lymphokine activated killer cells. Cancer Res. 48:(19):1988;5528.
28. Mier JW, Brandon EP, Libby P, Janicka MW, Aronson FR. Activated endothelial cells resist lymphokine-activated killer cell-mediated injury Possible role of induced cytokines in limiting capillary leak during IL-2 therapy . J Immunol. 143:(7):1989;2407.
29. Salvo G, Samoggia P, Masciulli R, Boccoli G, Allaven P, Mariani G, Bullo A, Montesoro E, Bulgarini D, Carlini P. Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity Role of cell adhesion to endothelium . Eur J Cancer. 28A:(4)(5):1992;818.
30. Kitayama J, Tsuno N, Yasuhara H, Nagawa H, Kimura W, Kuroda A, Shibata Y, Juji T, Muto T. Lysis of endothelial cells by autologous lymphokine-activated killer cells. Cancer Immunol Immunother. 38:(5):1994;317.
31. Bravery CA, Batten P, Yacoub MH, Rose ML. Direct recognition of SLA and HLA-like class II antigens on porcine endothelium by human T cells results in T cell activation and release of interleukin-2. Transplantation. 60:1995;1024.
32. Vallee I, Watier H, Thibault G, Salmon H, Gruel Y, Lebanchu Y, Bardos P. Evidence of noninvolvement of swine MHC class II in the in vitro proliferative response of human lymphocytes to porcine endothelial cells. Transplantation. 59:1995;897.
33. Siliciano RF, Pratt JC, Schmidt RE, Ritz J, Reinherz EL. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature. 317:(6036):1985;428.
34. Anasetti C, Martin PJ, Morishita Y, Badger CC, Bernstein ID, Hansen JA. Human large granular lymphocytes express high affinity receptors for murine monoclonal antibodies of the IgG3 subclass. J Immunol. 138:(9):1987;2979.
35. Bolhuis RL, Roozemond RC, van de Griend RJ. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. J Immunol. 136:(11):1986;3939.
36. Dustin ML, Sanders ME, Shaw S, Springer TA. Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion. J Exp Med. 165:(3):1987;677.
37. Arulanandam AR, Moingeon P, Concino MF, Recny MA, Kato K, Yagita H, Koyasu S, Reinherz EL. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2 divergence of CD2 ligands during the evolution of humans and mice . J Exp Med. 177:(5):1993;1439.
38. Sandrin MS, Mouhtouris E, Vaughan HA, Warren HS, Parish CR. CD48 is a low affinity ligand for human CD2. J Immunol. 151:(9):1993;4606.
39. Staunton DE, Fisher RC, LeBeau MM, Lawrence JB, Barton DE, Fancke Dustin M, Thorley-Lawson DA. Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23. J Exp Med. 169:(3):1989;1087.
40. Wallner BP, Frey AZ, Tizard R, Mattaliano RJ, Hession C, Sanders M, Dustin ML, Springer TA. Primary structure of lymphocyte function-associated antigen 3 (LFA-3) The ligand of the T lymphocyte CD2 glycoprotein . J Exp Med. 166:(4):1987;923.
41. Seed B. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature. 329:(6142):1987;840.
42. Artrip JH, Kwiatkowski P, Morgenthau A, Wang SF, Minanov O, Michler RE, Itescu S. Lysis of porcine endothelium by IL-2 activated primate mononuclear cells involves interactions with galactose alpha-1,3 galactose (Abstr.). J Heart Lung Transplant. 16:1997;59.
43. Qin L., Chavin KD, Lin J, Yagita H, Bromberg JS. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J Exp Med. 179:(1):1994;341.
44. Colonna M. Natural killer cell receptors specific for MHC class I molecules. Curr Opin Immunol. 8:1996;101.
45. Chong AS-F. Receptors that turn on and turn off natural killer cells. J Heart Lung Transplant. 15:1996;675.